Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat2
FARN Share
Trades7
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Faron Pharmaceuticals Information
Share Price Information for Faron Pharmaceuticals (FARN)
Share Price is delayed by 15 minutes
Get Live Data
43.50
0.00 (0.00%)
Bid:
42.00
Ask:
45.00
Spread:
3.00 (7.143%)
Market Cap:
£88.25m
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals News
18 Jan 2021
Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment
Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment
23 Nov 2020
IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3
IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3
24 Sep 2020
IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations
IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations
17 Sep 2020
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
18 Aug 2020
Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production
Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production
15 Jun 2020
IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product
IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product
15 Jun 2020
Faron Pharmaceuticals gets Finnish state loan for manufacturing process
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced plans to initiate a new "state-of-the-art" process for the...
11 Jun 2020
Faron receives EIC grant for 'MATINS' study
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has been selected to receive a €2.5m (£2.24m) grant from ...
Follow the stocks
